{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:25:47Z","timestamp":1781184347459,"version":"3.54.1"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To induce BCR-ABL gene silencing using CRISPR Cas13a.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>CML is a clonal myeloproliferative disorder of pluripotent stem cells driven by a reciprocal\ntranslocation between chromosomes 9 and 22 forming a BCR-ABL fusion gene. Tyrosine-\nkinase inhibitor drugs like imatinib are the mainstay of treatment and cases resistant to these\ndrugs have a poor prognosis in the absence of a compatible stem-cell donor. However with rapid\nadvancements in gene-editing technologies most studies are now focusing on developing a translational\nmodel targeting single-gene disorders with a prospective permanent cure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To explore the potential application of the RNA targeting CRISPR-Cas13a system for\neffective knockdown of BCR-ABL fusion transcript in a CML cell line K562.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>CRISPR Cas13a crRNA was designed specific to the chiCRISPR Cas13a crRNA was designed specific to the chimeric BCR-ABL gene and the\nsystem was transfected as a two-plasmid system into a CML cell line K562. The effects were enumerated\nby evaluating the expression levels of downstream genes dependent on the expression of\nthe BCR-ABL gene. Also next-generation sequencing was used to ascertain the effects of CRISPR\non the gene.meric BCR-ABL gene and the system was transfected as a two-plasmid system into a CML cell line, K562. The effects were enumerated by evaluating the expression levels of downstream genes dependent on the expression of the BCR-ABL gene. Also, next-generation sequencing was used to ascertain the effects of CRISPR on the gene.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The CRISPR system was successfully able to lower the expression of downstream genes\n[pCRKL and pCRK] dependent on the activated BCR-ABL kinase signal by up-to 4.3 folds. The viability\nof the CRISPR-treated cells was also significantly lowered by 373.83-fold [p-value=\n0.000891196]. The time-dependent kinetics also highlighted the significant in-vitro suppressive activity\nto last up to 8 weeks [p-value: 0.025]. As per the cDNA sequencing data from the Oxford\nMinION next-generation sequencer the CRISPR treated cells show 62.37% suspected cleaved\nreads.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These preliminary results highlight an excellent potential application of RNA targeting\nCRISPRs in Haematological neoplasms like CML and should pave the way for further research\nin this direction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1566523221666210217155233","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T23:05:57Z","timestamp":1613603157000},"page":"270-277","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effective Downregulation of BCR-ABL Tumorigenicity by RNA Targeted CRISPR-Cas13a"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-7429","authenticated-orcid":true,"given":"Aditya","family":"Singh","sequence":"first","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-3587","authenticated-orcid":true,"given":"Prateek","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh,India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"Shtivelman E.","year":"1985","unstructured":"Shtivelman E.; Lifshitz B.; Gale R.P.; Canaani E.; Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985,315(6020),550-554","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"Quint\u00e1s-Cardama A.","year":"2009","unstructured":"Quint\u00e1s-Cardama A.; Cortes J.; Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 2009,113(8),1619-1630","journal-title":"Blood"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2257.2002.00413.x","volume":"24","author":"Arana-Trejo R.M.","year":"2002","unstructured":"Arana-Trejo R.M.; Ru\u00edz S\u00e1nchez E.; Ignacio-Ibarra G.; B\u00e1ez de la Fuente E.; Garces O.; G\u00f3mez Morales E.; Castro Granados M.; Ovilla Mart\u00ednez R.; Rubio-Borja M.E.; Sol\u00eds Anaya L.; Herrera P.; Delgado Llamas J.; Kofman S.; BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clin Lab Haematol [CML].2002,24(3),145-150","journal-title":"Clin Lab Haematol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1182\/blood.V112.11.3365.3365","volume":"112","author":"Bruns I.","year":"2008","unstructured":"Bruns I.; Czibere A.; Cadeddu P.; Roels F.; Fischer J.C.; Buest S.; Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells. Blood 2008,112(11),1155","journal-title":"Blood"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"Gaj T.","year":"2013","unstructured":"Gaj T.; Gersbach C.A.; Barbas C.F.; ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 2013,31(7),397-405","journal-title":"Trends Biotechnol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.32607\/20758251-2014-6-3-19-40","volume":"6","author":"Nemudryi A.A.","year":"2014","unstructured":"Nemudryi A.A.; Valetdinova K.R.; Medvedev S.P.; Zakian S.M.; TALEN and CRISPR\/Cas Genome Editing Systems: Tools of Discovery. Acta Naturae 2014,6(3),19-40","journal-title":"Acta Naturae"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"11163","DOI":"10.1093\/nar\/gks875","volume":"40","author":"Mercer A.C.","year":"2012","unstructured":"Mercer A.C.; Gaj T.; Fuller R.P.; Barbas C.F.; Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res 2012,40(21),11163-11172","journal-title":"Nucleic Acids Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"26027","DOI":"10.18632\/oncotarget.15215","volume":"8","author":"Garc\u00eda-Tu\u00f1\u00f3n I.","year":"2017","unstructured":"Garc\u00eda-Tu\u00f1\u00f3n I.; Hern\u00e1ndez-S\u00e1nchez M.; Ordo\u00f1ez J.L.; Alonso-P\u00e9rez V.; \u00c1lamo-Quijada M.; Benito R.; Guerrero C.; Hern\u00e1ndez-Rivas J.M.; S\u00e1nchez-Mart\u00edn M.; The CRISPR\/Cas9 system efficiently reverts the tumorigenic ability of BCR\/ABL in vitro and in a xenograft model of chronic myeloid leukemia. Oncotarget 2017,8(16),26027-26040","journal-title":"Oncotarget"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/gm191","volume":"2","author":"Shibata Y.","year":"2010","unstructured":"Shibata Y.; Malhotra A.; Dutta A.; Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET. Genome Med 2010,2(9),70","journal-title":"Genome Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature24049","volume":"550","author":"Abudayyeh O.O.","year":"2017","unstructured":"Abudayyeh O.O.; Gootenberg J.S.; Essletzbichler P.; Han S.; Joung J.; Belanto J.J.; Verdine V.; Cox D.B.T.; Kellner M.J.; Regev A.; Lander E.S.; Voytas D.F.; Ting A.Y.; Zhang F.; RNA targeting with CRISPR-Cas13. Nature 2017,550(7675),280-284","journal-title":"Nature"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bioinformatics\/btx580","volume":"34","author":"Zhu H.","year":"2018","unstructured":"Zhu H.; Richmond E.; Liang C.; CRISPR-RT: a web application for designing CRISPR-C2c2 crRNA with improved target specificity. Bioinformatics 2018,34(1),117-119","journal-title":"Bioinformatics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-1862-1_10","volume":"1239","author":"Cong L.","year":"2015","unstructured":"Cong L.; Zhang F.;  Genome engineering using crispr-cas9 system 2015,1239,197-217","journal-title":"Genome engineering using crispr-cas9 system"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1 pdb.prot3932","DOI":"10.1101\/pdb.prot3932","author":"Sambrook J","year":"2006","unstructured":"Sambrook J; Russell DW; Preparation and Transformation of Competent E. coli Using Calcium Chloride. CSH Protoc 2006,1 pdb.prot3932","journal-title":"CSH Protoc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"Lozzio C.B.","year":"1975","unstructured":"Lozzio C.B.; Lozzio B.B.; Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975,45(3),321-334","journal-title":"Blood"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1093\/nar\/gkp1168","volume":"38","author":"Suzuki N.","year":"2010","unstructured":"Suzuki N.; Itou T.; Hasegawa Y.; Okazaki T.; Ikeno M.; Cell to cell transfer of the chromatin-packaged human beta-globin gene cluster. Nucleic Acids Res 2010,38(5),e33","journal-title":"Nucleic Acids Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1309\/60A9C8WGEGHRNXEE","volume":"120","author":"Jones C.D.","year":"2003","unstructured":"Jones C.D.; Yeung C.; Zehnder J.L.; Comprehensive validation of a real-time quantitative bcr-abl assay for clinical laboratory use. Am J Clin Pathol 2003,120(1),42-48","journal-title":"Am J Clin Pathol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"Schneider C.A.","year":"2012","unstructured":"Schneider C.A.; Rasband W.S.; Eliceiri K.W.; NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012,9(7),671-675","journal-title":"Nat Methods"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/bioinformatics\/bty149","volume":"34","author":"De Coster W.","year":"2018","unstructured":"De Coster W.; D\u2019Hert S.; Schultz D.T.; Cruts M.; Van Broeckhoven C.; NanoPack: visualizing and processing long-read sequencing data. Bioinformatics 2018,34(15),2666-2669","journal-title":"Bioinformatics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"Altschul S.F.","year":"1990","unstructured":"Altschul S.F.; Gish W.; Miller W.; Myers E.W.; Lipman D.J.; Basic local alignment search tool. J Mol Biol 1990,215(3),403-410","journal-title":"J Mol Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"Li H.","year":"2009","unstructured":"Li H.; Durbin R.; Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009,25(14),1754-1760","journal-title":"Bioinformatics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"Li H.","year":"2009","unstructured":"Li H.; Handsaker B.; Wysoker A.; Fennell T.; Ruan J.; Homer N.; Marth G.; Abecasis G.; Durbin R.; The Sequence Alignment\/Map format and SAMtools. Bioinformatics 1000 Genome Project Data Processing Subgroup2009,25(16),2078-2079","journal-title":"Bioinformatics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"Robinson J.T.","year":"2011","unstructured":"Robinson J.T.; Thorvaldsd\u00f3ttir H.; Winckler W.; Guttman M.; Lander E.S.; Getz G.; Mesirov J.P.; Integrative genomics viewer. Nat Biotechnol 2011,29(1),24-26","journal-title":"Nat Biotechnol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12185-016-2017-z","volume":"104","author":"Osborn M.J.","year":"2016","unstructured":"Osborn M.J.; Belanto J.J.; Tolar J.; Voytas D.F.; Gene editing and its application for hematological diseases. Int J Hematol 2016,104(1),18-28","journal-title":"Int J Hematol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1039\/C8BM00263K","volume":"6","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Zhao G.; Xu C.F.; Luo Y.L.; Lu Z.D.; Wang J.; Systemic delivery of CRISPR\/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy. Biomater Sci 2018,6(6),1592-1603","journal-title":"Biomater Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e0216674","DOI":"10.1371\/journal.pone.0216674","volume":"14","author":"Garc\u00eda-Tu\u00f1\u00f3n I.","year":"2019","unstructured":"Garc\u00eda-Tu\u00f1\u00f3n I.; Alonso-P\u00e9rez V.; Vuelta E.; P\u00e9rez-Ramos S.; Herrero M.; M\u00e9ndez L.; Hern\u00e1ndez-S\u00e1nchez J.M.; Mart\u00edn-Izquierdo M.; Salda\u00f1a R.; Sevilla J.; S\u00e1nchez-Guijo F.; Hern\u00e1ndez-Rivas J.M.; S\u00e1nchez-Mart\u00edn M.; Splice donor site sgRNAs enhance CRISPR\/Cas9-mediated knockout efficiency. PLoS One 2019,14(5),e0216674","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.;  Nucleic Acids Research 2000,28,27-30","journal-title":"Nucleic Acids Research"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/tpj.13899","volume":"94","author":"Wolter F.","year":"2018","unstructured":"Wolter F.; Puchta H.; The CRISPR\/Cas revolution reaches the RNA world: Cas13, a new Swiss Army knife for plant biologists. Plant J 2018,94(5),767-775","journal-title":"Plant J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.leu.2404189","volume":"20","author":"Hamilton A.","year":"2006","unstructured":"Hamilton A.; Elrick L.; Myssina S.; Copland M.; J\u00f8rgensen H.; Melo J.V.; Holyoake T.; BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry. Leukemia 2006,20(6),1035-1039","journal-title":"Leukemia"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","volume":"52","author":"Wilbie D.","year":"2019","unstructured":"Wilbie D.; Walther J.; Mastrobattista E.; Delivery Aspects of CRISPR\/Cas for in Vivo Genome Editing. Acc Chem Res 2019,52(6),1555-1564","journal-title":"Acc Chem Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","volume":"358","author":"Cox D.B.T.","year":"2017","unstructured":"Cox D.B.T.; Gootenberg J.S.; Abudayyeh O.O.; Franklin B.; Kellner M.J.; Joung J.; Zhang F.; RNA editing with CRISPR-Cas13. Science 2017,358(6366),1019-1027","journal-title":"Science"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523221666210217155233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191520\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523221666210217155233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T01:50:20Z","timestamp":1660009820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191520\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523221666210217155233","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/840900","asserted-by":"object"}]},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}